Tridek-One, Paris, November 25, 2019 – Tridek One, a biotech company specialized in the development of products for the treatment of immune disorders, announces today the appointment of Régis Olivier as Chief Executive Officer. He replaces Philippe Berthon.
Régis Olivier has joined the company in april 2019 as Chief Financial Officer.
Continue reading “Appointment of Régis Olivier as Chief Executive Officer of Tridek-One”
The biotech Tridek-One strengthens its executive team with the appointments of:
Olivier as Chief Financial Officer
Dr Jorge Kirilovsky as Chief Scientific Officer
Tridek-One, Evry-Génopole, October 2, 2019 – Tridek One, a French biotechnology company specializing in the development of products for the treatment of immune and inflammatory disorders, today announced the strengthening of its management team with the appointments of Regis Olivier to the position of Chief Financial Officer and Dr Jorge Kirilovsky as Chief Scientific Officer. Régis, and Jorge join the Executive Committee of the company.
Continue reading “The biotech Tridek-One strengthens its executive team”
Tridek One, Paris, June 4, 2019 – Tridek One, a biotech company specialized in the development of products for the treatment of immune disorders, is pleased to announce a first round of funding of 3 million euros with leading investors Advent France Biotechnology and Advent Life Sciences.
Two investment funds accompanying us in the development, Advent France Biotechnology and Advent Life Sciences which co-invested in the seed series.
